Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention

Streptococcus pneumoniae is an infectious pathogen responsible for millions of deaths worldwide. Diseases caused by this bacterium are classified as pneumococcal diseases. This pathogen colonizes the nasopharynx of its host asymptomatically, but overtime can migrate to sterile tissues and organs and cause infections. Pneumonia is currently the most common pneumococcal disease. Pneumococcal pneumonia is a global health concern and vastly affects children under the age of five as well as the elderly and individuals with pre-existing health conditions. S. pneumoniae has a large selection of virulence factors that promote adherence, invasion of host tissues, and allows it to escape host immune defenses. A clear understanding of S. pneumoniae’s virulence factors, host immune responses, and examining the current techniques available for diagnosis, treatment, and disease prevention will allow for better regulation of the pathogen and its diseases. In terms of disease prevention, other considerations must include the effects of age on responses to vaccines and vaccine efficacy. Ongoing work aims to improve on current vaccination paradigms by including the use of serotype-independent vaccines, such as protein and whole cell vaccines. Extending our knowledge of the biology of, and associated host immune response to S. pneumoniae is paramount for our improvement of pneumococcal disease diagnosis, treatment, and improvement of patient outlook.

[1]  Antibiotic resistance threats in the United States, 2019 , 2019 .

[2]  J. Weiser,et al.  Streptococcus pneumoniae: transmission, colonization and invasion , 2018, Nature Reviews Microbiology.

[3]  T. Kilpi,et al.  Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial. , 2018, Vaccine.

[4]  M. Khan,et al.  Molecular Characterization of Pneumococcal Surface Protein A (PspA), Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Isolated from Pakistan , 2018, Infectious Diseases and Therapy.

[5]  A. Choi,et al.  NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[6]  Xinyuan Zhang,et al.  Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection , 2018, Front. Immunol..

[7]  Douglas I. Johnson Bacterial Pathogens and Their Virulence Factors , 2017, Springer International Publishing.

[8]  P. Sly,et al.  Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children , 2017, Respirology.

[9]  K. Mulholland Problems with the WHO guidelines for management of childhood pneumonia. , 2018, The Lancet. Global health.

[10]  Joon Beom Seo,et al.  Development of a Computer-Aided Differential Diagnosis System to Distinguish Between Usual Interstitial Pneumonia and Non-specific Interstitial Pneumonia Using Texture- and Shape-Based Hierarchical Classifiers on HRCT Images , 2018, Journal of Digital Imaging.

[11]  Eyal Oren,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.

[12]  Vincenzo Carnevale,et al.  Assessment of thoracic ultrasound in complementary diagnosis and in follow up of community-acquired pneumonia (cap) , 2017, BMC Medical Imaging.

[13]  K. O'Brien,et al.  Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities , 2017, Epidemiology and Infection.

[14]  P. Schmieder,et al.  Structure of the competence pilus major pilin ComGC in Streptococcus pneumoniae , 2017, The Journal of Biological Chemistry.

[15]  H. Tettelin,et al.  Transcriptional organization of pneumococcal psrP-secY2A2 and impact of GtfA and GtfB deletion on PsrP-associated virulence properties. , 2017, Microbes and infection.

[16]  O. Fufezan,et al.  Performance of lung ultrasonography for the diagnosis of communityacquired pneumonia in hospitalized children. , 2017, Medical ultrasonography.

[17]  A. Gervaix,et al.  A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR , 2017, European Journal of Pediatrics.

[18]  M. Epstein,et al.  Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications , 2017, American journal of therapeutics.

[19]  S. Bergmann,et al.  Impact of Streptococcal Enolase in Virulence , 2017 .

[20]  W. Edmunds,et al.  Identifying human encounters that shape the transmission of Streptococcus pneumoniae and other acute respiratory infections , 2018, Epidemics.

[21]  E. Shapiro,et al.  Developing Better Pneumococcal Vaccines for Adults , 2017, JAMA internal medicine.

[22]  K. Ariyoshi,et al.  Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. , 2017, The Lancet. Infectious diseases.

[23]  D. Musher,et al.  White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia , 2017, Open forum infectious diseases.

[24]  E. Eisenmesser,et al.  Streptococcus pneumoniae IgA1 protease: A metalloprotease that can catalyze in a split manner in vitro , 2017, Protein science : a publication of the Protein Society.

[25]  David Goldblatt,et al.  Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration , 2017, bioRxiv.

[26]  Qing‐Yu He,et al.  Crucial residue Trp158 of lipoprotein PiaA stabilizes the ferrichrome-PiaA complex in Streptococcus pneumoniae. , 2017, Journal of inorganic biochemistry.

[27]  Jeremy Anderson,et al.  The contrasting roles of Th17 immunity in human health and disease , 2017, Microbiology and immunology.

[28]  J. Weiser,et al.  Host-to-Host Transmission of Streptococcus pneumoniae Is Driven by Its Inflammatory Toxin, Pneumolysin. , 2017, Cell host & microbe.

[29]  Ling Long,et al.  Lung ultrasound for the diagnosis of pneumonia in adults , 2017, Medicine.

[30]  L. Bakaletz Viral–bacterial co-infections in the respiratory tract , 2016, Current Opinion in Microbiology.

[31]  P. Royle,et al.  Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. , 2017, The Lancet. Global health.

[32]  H. Mikamo,et al.  Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review , 2017, BMC Research Notes.

[33]  H. Endtz,et al.  Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study , 2016, Scientific Reports.

[34]  M. Pichichero,et al.  Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection , 2016, Infection and Immunity.

[35]  Franziska Voß,et al.  Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion , 2016, FEBS letters.

[36]  D. Olson,et al.  Use of PCV13 and PPSV23 in Adult Population: Are We Following the Advisory Committee on Immunization Practices Recommendations? , 2016 .

[37]  V. Appay,et al.  Aging of the immune system: Focus on inflammation and vaccination , 2016, European journal of immunology.

[38]  K. Bennett,et al.  Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial , 2016, Scientific Reports.

[39]  Ronald Anderson,et al.  Epidemiology, virulence factors and management of the pneumococcus , 2016, F1000Research.

[40]  Li-Min Huang,et al.  Is Pneumococcal Serotype Replacement Impending? , 2016, Pediatrics and neonatology.

[41]  A. Shaw,et al.  Host Resistance and Immune Aging. , 2016, Clinics in geriatric medicine.

[42]  E. Klein,et al.  The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis , 2016, Influenza and other respiratory viruses.

[43]  C. D. Dela Cruz,et al.  Pneumococcal Vaccination Strategies. An Update and Perspective. , 2016, Annals of the American Thoracic Society.

[44]  B. Maestro,et al.  Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials , 2016, Antibiotics.

[45]  Haley R Pipkins,et al.  Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media , 2016, Front. Cell. Infect. Microbiol..

[46]  L. McGee,et al.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective , 2016, Clinical Microbiology Reviews.

[47]  J. Kwang,et al.  Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest , 2016, Scientific Reports.

[48]  Harvard Medical School,et al.  Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis , 2016, mBio.

[49]  L. Ostrowski,et al.  Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[50]  Chasity M. Shelton,et al.  A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens. , 2016, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

[51]  E. Tuomanen,et al.  Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium , 2016, Nature Communications.

[52]  Qing-Yu He,et al.  Integrated Translatomics with Proteomics to Identify Novel Iron–Transporting Proteins in Streptococcus pneumoniae , 2016, Front. Microbiol..

[53]  R. Malley,et al.  Rationale and prospects for novel pneumococcal vaccines , 2016, Human vaccines & immunotherapeutics.

[54]  D. Briles,et al.  Pneumolysin plays a key role at the initial step of establishing pneumococcal nasal colonization , 2016, Folia Microbiologica.

[55]  Julie G. Burel,et al.  Systems Approaches towards Molecular Profiling of Human Immunity. , 2016, Trends in immunology.

[56]  N. Suttorp,et al.  Inflammasomes in Pneumococcal Infection: Innate Immune Sensing and Bacterial Evasion Strategies. , 2016, Current topics in microbiology and immunology.

[57]  J. Lord,et al.  Immune ageing and susceptibility to Streptococcus pneumoniae , 2015, Biogerontology.

[58]  A. McMichael,et al.  Evolution of the immune system in humans from infancy to old age , 2015, Proceedings of the Royal Society B: Biological Sciences.

[59]  L. Leite,et al.  Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing. , 2015, Microbial pathogenesis.

[60]  B. Kobe,et al.  Characterizing the conformational dynamics of metal-free PsaA using molecular dynamics simulations and electron paramagnetic resonance spectroscopy. , 2015, Biophysical chemistry.

[61]  M. Kollef,et al.  Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults , 2015, Medicine.

[62]  Rianne Fijten,et al.  Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia , 2015, Scientific Reports.

[63]  T. Pilishvili,et al.  Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. , 2015, Vaccine.

[64]  Ernesto García,et al.  In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes. , 2015, Environmental microbiology reports.

[65]  J. Crapo,et al.  Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study , 2015, Respiratory Research.

[66]  C. Whitney,et al.  Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2015, MMWR. Morbidity and mortality weekly report.

[67]  Md. Arif Sheikh,et al.  The Crystal Structure of Pneumolysin at 2.0 Å Resolution Reveals the Molecular Packing of the Pre-pore Complex , 2015, Scientific Reports.

[68]  Melonie P. Heron Deaths: Leading Causes for 2012. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[69]  J. Kilby,et al.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection. , 2015, Vaccine.

[70]  M. Ohnishi,et al.  Capsule Switching and Antimicrobial Resistance Acquired during Repeated Streptococcus pneumoniae Pneumonia Episodes , 2015, Journal of Clinical Microbiology.

[71]  F. Blasi,et al.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease , 2015, Thorax.

[72]  J. Koeck,et al.  Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines , 2015, PloS one.

[73]  D. Su,et al.  Thymic involution beyond T-cell insufficiency , 2015, Oncotarget.

[74]  S. Tan,et al.  Alexander Fleming (1881-1955): Discoverer of penicillin. , 2015, Singapore medical journal.

[75]  M. Nahm,et al.  Pneumococcal Capsules and Their Types: Past, Present, and Future , 2015, Clinical Microbiology Reviews.

[76]  J. Kwang,et al.  Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells , 2015, Proceedings of the National Academy of Sciences.

[77]  J. Stek,et al.  Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. , 2015, Vaccine.

[78]  J. McCullers,et al.  Mechanisms of Predisposition to Pneumonia , 2015 .

[79]  T. Vernet,et al.  Streptococcus pneumoniae GAPDH Is Released by Cell Lysis and Interacts with Peptidoglycan , 2015, PloS one.

[80]  D. Grobbee,et al.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. , 2015, The New England journal of medicine.

[81]  Jamie K. Lemon,et al.  Degradation Products of the Extracellular Pathogen Streptococcus pneumoniae Access the Cytosol via Its Pore-Forming Toxin , 2015, mBio.

[82]  S. Hammerschmidt,et al.  Pneumococcal hydrogen peroxide-induced stress signaling regulates inflammatory genes. , 2015, The Journal of infectious diseases.

[83]  A. Hakansson,et al.  Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease , 2015, Front. Cell. Infect. Microbiol..

[84]  N. Høiby,et al.  Strategies for combating bacterial biofilm infections , 2014, International Journal of Oral Science.

[85]  R. Wilson,et al.  Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses , 2014, Mucosal Immunology.

[86]  Aldert L. Zomer,et al.  Non-Adhesive Surface Proteins of Streptococcus pneumoniae , 2015 .

[87]  K. Peters,et al.  The Pneumococcal Cell Wall , 2015 .

[88]  Jeremy S. Brown,et al.  Streptococcus pneumoniae Interactions with Macrophages and Mechanisms of Immune Evasion , 2015 .

[89]  W. Swords,et al.  Pneumococcal Biofilms and Bacterial Persistence During Otitis Media Infections , 2015 .

[90]  J. Hermoso,et al.  Structure and Function of Choline-Binding Proteins , 2015 .

[91]  L. McGee,et al.  Antibiotic Resistance of Pneumococci , 2015 .

[92]  H. Tettelin,et al.  Genomics, Genetic Variation, and Regions of Differences , 2015 .

[93]  A. Kadioglu,et al.  Chapter 14 – Pneumolysin , 2015 .

[94]  L. Cauley,et al.  Why is coinfection with influenza virus and bacteria so difficult to control? , 2015, Discovery medicine.

[95]  M. Pichichero,et al.  The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development , 2014, Human vaccines & immunotherapeutics.

[96]  B. Kroesen,et al.  Aging disturbs the balance between effector and regulatory CD4+ T cells , 2014, Experimental Gerontology.

[97]  F. Sánchez‐Madrid,et al.  Pleiotropic Effects of Cell Wall Amidase LytA on Streptococcus pneumoniae Sensitivity to the Host Immune Response , 2014, Infection and Immunity.

[98]  Hong Wang,et al.  Mucosal Immunization with the Live Attenuated Vaccine SPY1 Induces Humoral and Th2-Th17-Regulatory T Cell Cellular Immunity and Protects against Pneumococcal Infection , 2014, Infection and Immunity.

[99]  K. L. Nawrocki,et al.  Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria , 2014, Antibiotics.

[100]  A. Descoteaux,et al.  Macrophage Cytokines: Involvement in Immunity and Infectious Diseases , 2014, Front. Immunol..

[101]  Umed Ajani,et al.  Summary of notifiable diseases--United States, 2012. , 2014, MMWR. Morbidity and mortality weekly report.

[102]  C. Whitney,et al.  Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2014, MMWR. Morbidity and mortality weekly report.

[103]  P. Skipp,et al.  Pronounced Metabolic Changes in Adaptation to Biofilm Growth by Streptococcus pneumoniae , 2014, PloS one.

[104]  N. Andrews,et al.  Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. , 2014, The Lancet. Infectious diseases.

[105]  Qing‐Yu He,et al.  Chemical Interference with Iron Transport Systems to Suppress Bacterial Growth of Streptococcus pneumoniae , 2014, PloS one.

[106]  J. Casanova,et al.  TLR-Mediated Inflammatory Responses to Streptococcus pneumoniae Are Highly Dependent on Surface Expression of Bacterial Lipoproteins , 2014, The Journal of Immunology.

[107]  R. Adegbola,et al.  Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis , 2014, PloS one.

[108]  J. Yagüe,et al.  The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response , 2014, Nature Immunology.

[109]  P. Polgreen,et al.  Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers. , 2014, Diagnostic microbiology and infectious disease.

[110]  S. Siegel,et al.  TLR2 Signaling Decreases Transmission of Streptococcus pneumoniae by Limiting Bacterial Shedding in an Infant Mouse Influenza A Co-infection Model , 2014, PLoS pathogens.

[111]  Cong-Zhao Zhou,et al.  Structure of Pneumococcal Peptidoglycan Hydrolase LytB Reveals Insights into the Bacterial Cell Wall Remodeling and Pathogenesis* , 2014, The Journal of Biological Chemistry.

[112]  M. A. Chavez,et al.  Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis , 2014, Respiratory Research.

[113]  M. Kirschfink,et al.  Complement Profile in Neonates of Different Gestational Ages , 2014, Scandinavian journal of immunology.

[114]  Lucia H. Lee,et al.  Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention , 2014, Vaccines.

[115]  D. Svergun,et al.  Structural and Functional Insights into Peptidoglycan Access for the Lytic Amidase LytA of Streptococcus pneumoniae , 2014, mBio.

[116]  Richard G. Wunderink,et al.  Clinical practice. Community-acquired pneumonia. , 2014, The New England journal of medicine.

[117]  A. Simonetti,et al.  Management of community-acquired pneumonia in older adults , 2014, Therapeutic advances in infectious disease.

[118]  Thomas Geeraerts,et al.  Performance comparison of lung ultrasound and chest x-ray for the diagnosis of pneumonia in the ED. , 2014, The American journal of emergency medicine.

[119]  K. O'Brien,et al.  Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use , 2014, PloS one.

[120]  R. Stockley,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly : toward targeted treatments for immunosenescence , 2013 .

[121]  C. Castelo-Branco,et al.  The immune system and aging: a review , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[122]  J. Rubins,et al.  Pneumococcal IgA1 Protease Subverts Specific Protection By Human IgA1 , 2013, Mucosal Immunology.

[123]  H. Ovens,et al.  Community-acquired pneumonia. , 2014, The New England journal of medicine.

[124]  J. Whitsett,et al.  Respiratory epithelial cells orchestrate pulmonary innate immunity , 2014, Nature Immunology.

[125]  A. Hakansson,et al.  Biofilm Formation Enhances Fomite Survival of Streptococcus pneumoniae and Streptococcus pyogenes , 2013, Infection and Immunity.

[126]  Charles Feldman,et al.  Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease , 2013, Mediators of inflammation.

[127]  J. Rosch,et al.  The roles of transition metals in the physiology and pathogenesis of Streptococcus pneumoniae , 2013, Front. Cell. Infect. Microbiol..

[128]  M. Nahm,et al.  Diagnosis of Pneumococcal Pneumonia: Current Pitfalls and the Way Forward , 2013, Infection & chemotherapy.

[129]  A. Jansen,et al.  A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. , 2013, Vaccine.

[130]  M. Hackel,et al.  Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. , 2013, Vaccine.

[131]  Robert E W Hancock,et al.  Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. , 2013, Current opinion in microbiology.

[132]  M. Lipsitch,et al.  Surface Charge of Streptococcus pneumoniae Predicts Serotype Distribution , 2013, Infection and Immunity.

[133]  H. Yi,et al.  Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of Biofilms , 2013, mBio.

[134]  Yuxing Chen,et al.  Structures of Streptococcus pneumoniae PiaA and Its Complex with Ferrichrome Reveal Insights into the Substrate Binding and Release of High Affinity Iron Transporters , 2013, PloS one.

[135]  C. Whitney,et al.  Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2013, MMWR. Morbidity and mortality weekly report.

[136]  G. Giudice,et al.  Expression of the Streptococcus pneumoniae pilus-1 undergoes on and off switching during colonization in mice , 2013, Scientific Reports.

[137]  E. Le Cam,et al.  A Type IV Pilus Mediates DNA Binding during Natural Transformation in Streptococcus pneumoniae , 2013, PLoS pathogens.

[138]  P. Andrew,et al.  Streptococcus pneumoniae and reactive oxygen species: an unusual approach to living with radicals. , 2013, Trends in microbiology.

[139]  P. Gibson,et al.  Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD , 2013, Mediators of inflammation.

[140]  M. Fliegauf,et al.  Mucociliary Clearance Defects in a Murine In Vitro Model of Pneumococcal Airway Infection , 2013, PloS one.

[141]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[142]  D. Frommhold,et al.  Neutrophil and endothelial adhesive function during human fetal ontogeny , 2013, Journal of leukocyte biology.

[143]  S. Gurunathan,et al.  Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults. , 2013, Vaccine.

[144]  N. Warner,et al.  MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction , 2013, The Journal of Immunology.

[145]  J. Parkhill,et al.  Pneumococcal Capsular Switching: A Historical Perspective , 2012, The Journal of infectious diseases.

[146]  D. Golenbock,et al.  Defective pro-IL-1β responses in macrophages from aged mice , 2012, Immunity & Ageing.

[147]  R. Andrews,et al.  Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction. , 2012, Blood reviews.

[148]  D. Rhee,et al.  Pneumococcal Surface Protein A Inhibits Complement Deposition on the Pneumococcal Surface by Competing with the Binding of C-Reactive Protein to Cell-Surface Phosphocholine , 2012, The Journal of Immunology.

[149]  Á. Díaz-Ramos,et al.  α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations , 2012, Journal of biomedicine & biotechnology.

[150]  A. Blom,et al.  Enolase of Streptococcus pneumoniae Binds Human Complement Inhibitor C4b-Binding Protein and Contributes to Complement Evasion , 2012, The Journal of Immunology.

[151]  A. Hakansson,et al.  High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae , 2012, mBio.

[152]  I. Korona-Głowniak,et al.  Characteristics of Streptococcus pneumoniae Strains Colonizing Upper Respiratory Tract of Healthy Preschool Children in Poland , 2012, TheScientificWorldJournal.

[153]  E. Varon Epidemiology of Streptococcus pneumoniae. , 2012, Medecine et maladies infectieuses.

[154]  J. Hermoso,et al.  Pneumococcal surface proteins: when the whole is greater than the sum of its parts. , 2012, Molecular oral microbiology.

[155]  C. Orihuela,et al.  Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia , 2012, Experimental Gerontology.

[156]  S. Bentley,et al.  Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. , 2012, Microbes and infection.

[157]  A. D'Amour,et al.  Estimating Rates of Carriage Acquisition and Clearance and Competitive Ability for Pneumococcal Serotypes in Kenya With a Markov Transition Model , 2012, Epidemiology.

[158]  P. Andrew,et al.  The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection , 2012, PLoS pathogens.

[159]  A. Hakansson,et al.  Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and Colonization In Vitro and In Vivo , 2012, Infection and Immunity.

[160]  L. McDaniel,et al.  Nontypeable Pneumococci Can Be Divided into Multiple cps Types, Including One Type Expressing the Novel Gene pspK , 2012, mBio.

[161]  Matthew R Moore,et al.  Aging population and future burden of pneumococcal pneumonia in the United States. , 2012, The Journal of infectious diseases.

[162]  K. Mulholland,et al.  Serotype replacement after pneumococcal vaccination , 2012, The Lancet.

[163]  P. Chavanet Pneumococcus infections: is the burden still as heavy? , 2012, Medecine et maladies infectieuses.

[164]  P. Rohani,et al.  Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns. , 2012, American journal of epidemiology.

[165]  A. Tomasz,et al.  Isolation and analysis of cell wall components from Streptococcus pneumoniae. , 2012, Analytical biochemistry.

[166]  S. Normark,et al.  LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent Peptidoglycan* , 2012, The Journal of Biological Chemistry.

[167]  S. Hamada,et al.  α-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps* , 2012, The Journal of Biological Chemistry.

[168]  M. Nahm,et al.  Issues and challenges in the development of pneumococcal protein vaccines , 2012, Expert review of vaccines.

[169]  M. Nahm,et al.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. , 2012, Aging and disease.

[170]  Robin Patel,et al.  The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic Sensitization , 2011, International journal of microbiology.

[171]  J. Woof,et al.  Structure and function relationships in IgA , 2011, Mucosal Immunology.

[172]  John S. Bradley,et al.  The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[173]  K. Klugman,et al.  The future of pneumococcal disease prevention. , 2011, Vaccine.

[174]  Kimberly M. Davis,et al.  Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. , 2011, The Journal of clinical investigation.

[175]  J. Yuste,et al.  Nasopharyngeal Colonization and Invasive Disease Are Enhanced by the Cell Wall Hydrolases LytB and LytC of Streptococcus pneumoniae , 2011, PloS one.

[176]  R. Klevens,et al.  Manual for the surveillance of vaccine-preventable diseases. Chapter 3: Hepatitis A , 2011 .

[177]  S. Hem,et al.  Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response , 2011, Journal of immune based therapies and vaccines.

[178]  W. Pomat,et al.  Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance , 2011, Vaccine.

[179]  J. Tschopp,et al.  The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia , 2011, The Journal of Immunology.

[180]  Diederik van de Beek,et al.  Pathogenesis and Pathophysiology of Pneumococcal Meningitis , 2011, Clinical Microbiology Reviews.

[181]  C. Donati,et al.  The Streptococcus pneumoniae Pilus-1 Displays a Biphasic Expression Pattern , 2011, PloS one.

[182]  S. Bencharit,et al.  Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. , 2011, Omics : a journal of integrative biology.

[183]  A. Camilli,et al.  Streptococcus pneumoniae Is Desiccation Tolerant and Infectious upon Rehydration , 2011, mBio.

[184]  A. Varvarigou,et al.  Phagocytic ability of neutrophils and monocytes in neonates , 2011, BMC pediatrics.

[185]  A. Reunanen,et al.  Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. , 2011, Vaccine.

[186]  K. Ariyoshi,et al.  Association Between Nasopharyngeal Load of Streptococcus pneumoniae, Viral Coinfection, and Radiologically Confirmed Pneumonia in Vietnamese Children , 2011, The Pediatric infectious disease journal.

[187]  J. Tschopp,et al.  Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4 , 2010, PLoS pathogens.

[188]  David R. Riley,et al.  Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species , 2010, Genome Biology.

[189]  Justin S. Hogg,et al.  Generation of Genic Diversity among Streptococcus pneumoniae Strains via Horizontal Gene Transfer during a Chronic Polyclonal Pediatric Infection , 2010, PLoS pathogens.

[190]  C. Orihuela,et al.  The Pneumococcal Serine-Rich Repeat Protein Is an Intra-Species Bacterial Adhesin That Promotes Bacterial Aggregation In Vivo and in Biofilms , 2010, PLoS pathogens.

[191]  T. Mitchell,et al.  Streptococcus pneumoniae: virulence factors and variation. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[192]  J. García,et al.  Insights into pneumococcal fratricide from the crystal structures of the modular killing factor LytC , 2010, Nature Structural &Molecular Biology.

[193]  T. Poll,et al.  Role of CD14 in Lung Inflammation and Infection , 2011, Intensive Care Medicine.

[194]  D. Isaacman,et al.  Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[195]  M. de Martino,et al.  Realtime PCR Is More Sensitive than Multiplex PCR for Diagnosis and Serotyping in Children with Culture Negative Pneumococcal Invasive Disease , 2010, PloS one.

[196]  Recommended immunization schedule for persons aged 7 through 18 years , 2010, AAP News.

[197]  C. Whitney,et al.  Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). , 2010, MMWR. Morbidity and mortality weekly report.

[198]  B. Yawn,et al.  Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. , 2010, The Journal of allergy and clinical immunology.

[199]  W. Schaffner,et al.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.

[200]  D. Morens,et al.  Bacterial pathogens and death during the 1918 influenza pandemic. , 2009, The New England journal of medicine.

[201]  Jeremy S. Brown,et al.  The Streptococcuspneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms , 2009, Infection and Immunity.

[202]  Antonio Anzueto,et al.  Community-acquired pneumonia in elderly patients. , 2009, Aging health.

[203]  S. Opal,et al.  Pathogenesis, treatment, and prevention of pneumococcal pneumonia , 2009, The Lancet.

[204]  P. Murray Beyond peptidoglycan for Nod2 , 2009, Nature Immunology.

[205]  C. Orihuela,et al.  The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells , 2009, Molecular microbiology.

[206]  M. Rohde,et al.  Pneumococcal Interaction with Human Dendritic Cells: Phagocytosis, Survival, and Induced Adaptive Immune Response Are Manipulated by PavA1 , 2009, Journal of Immunology.

[207]  G. Pawelec,et al.  Mechanisms of immunosenescence , 2009, Immunity & Ageing.

[208]  L. Turka,et al.  The contribution of direct TLR signaling to T cell responses , 2009, Immunologic research.

[209]  B. Best Nuclear DNA damage as a direct cause of aging. , 2009, Rejuvenation research.

[210]  V. Eldholm,et al.  Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD, LytA and LytC. , 2009, Microbiology.

[211]  S. Shelburne,et al.  Inhaled therapeutics for prevention and treatment of pneumonia , 2009, Expert opinion on drug safety.

[212]  A. Blom,et al.  Clinical Isolates of Streptococcus pneumoniae Bind the Complement Inhibitor C4b-Binding Protein in a PspC Allele-Dependent Fashion1 , 2009, The Journal of Immunology.

[213]  A. Martner,et al.  Streptococcus pneumoniae Autolysis Prevents Phagocytosis and Production of Phagocyte-Activating Cytokines , 2009, Infection and Immunity.

[214]  R. Dagan,et al.  Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. , 2009, Vaccine.

[215]  Shan Lu Heterologous prime-boost vaccination. , 2009, Current opinion in immunology.

[216]  C. Bryant,et al.  Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer , 2009, Pharmacological Reviews.

[217]  R. Reinert The antimicrobial resistance profile of Streptococcus pneumoniae. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[218]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[219]  A. Pollard,et al.  Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines , 2009, Nature Reviews Immunology.

[220]  N. Campillo,et al.  Crystal structure of CbpF, a bifunctional choline‐binding protein and autolysis regulator from Streptococcus pneumoniae , 2009, EMBO reports.

[221]  R. Lodha,et al.  Factors determining the outcome of children hospitalized with severe pneumonia , 2009, BMC pediatrics.

[222]  N. Warner,et al.  Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.

[223]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[224]  Kimberly M. Davis,et al.  Resistance to Mucosal Lysozyme Compensates for the Fitness Deficit of Peptidoglycan Modifications by Streptococcus pneumoniae , 2008, PLoS pathogens.

[225]  S. Jeyaseelan,et al.  Neutrophil Recruitment to the Lungs during Bacterial Pneumonia , 2008, Infection and Immunity.

[226]  D. Musher,et al.  Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. , 2008, The Journal of infectious diseases.

[227]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[228]  G. Dennis Shanks,et al.  Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic , 2008, Emerging infectious diseases.

[229]  A. Martner,et al.  Pneumolysin Released during Streptococcus pneumoniae Autolysis Is a Potent Activator of Intracellular Oxygen Radical Production in Neutrophils , 2008, Infection and Immunity.

[230]  C. Donati,et al.  A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells , 2008, Journal of bacteriology.

[231]  Jeffrey N. Weiser,et al.  The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease , 2008, Nature Reviews Microbiology.

[232]  D. Murdoch,et al.  Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[233]  T. van der Poll,et al.  Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. , 2008, The Journal of infectious diseases.

[234]  G. Rajam,et al.  Pneumococcal Surface Adhesin A (PsaA): A Review , 2008 .

[235]  P. Andrew,et al.  The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae. , 2008, FEMS microbiology letters.

[236]  23-valent pneumococcal polysaccharide vaccine. WHO position paper. , 2008, Releve epidemiologique hebdomadaire.

[237]  João André Carriço,et al.  High Rates of Transmission of and Colonization by Streptococcus pneumoniae and Haemophilus influenzae within a Day Care Center Revealed in a Longitudinal Study , 2007, Journal of Clinical Microbiology.

[238]  V. Kolb-Bachofen,et al.  Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands , 2007, Clinical and Vaccine Immunology.

[239]  S. Clarke,et al.  Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. , 2007, The Journal of infectious diseases.

[240]  Nathan D. Wolfe,et al.  Origins of major human infectious diseases , 2007, Nature.

[241]  S. Normark,et al.  Capsule and d‐alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps , 2007, Cellular microbiology.

[242]  D. Aw,et al.  Immunosenescence: emerging challenges for an ageing population , 2007, Immunology.

[243]  T. van der Poll,et al.  CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. , 2007, American journal of respiratory and critical care medicine.

[244]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[245]  Z. Cohen,et al.  Effect of hydrogen peroxide production and the Fenton reaction on membrane composition of Streptococcus pneumoniae. , 2007, Biochimica et biophysica acta.

[246]  N. Cohen,et al.  Mucociliary clearance – a critical upper airway host defense mechanism and methods of assessment , 2007, Current opinion in allergy and clinical immunology.

[247]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[248]  A. Nelson,et al.  Capsule Enhances Pneumococcal Colonization by Limiting Mucus-Mediated Clearance , 2006, Infection and Immunity.

[249]  Bernard Martin,et al.  Induction of competence regulons as a general response to stress in gram-positive bacteria. , 2006, Annual review of microbiology.

[250]  T. Mitchell,et al.  The Contribution of PspC to Pneumococcal Virulence Varies between Strains and Is Accomplished by Both Complement Evasion and Complement-Independent Mechanisms , 2006, Infection and Immunity.

[251]  W. Vollmer,et al.  A Functional dlt Operon, Encoding Proteins Required for Incorporation of d-Alanine in Teichoic Acids in Gram-Positive Bacteria, Confers Resistance to Cationic Antimicrobial Peptides in Streptococcus pneumoniae , 2006, Journal of bacteriology.

[252]  M. Rohde,et al.  Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. , 2006, Microbiology.

[253]  L. Marraffini,et al.  Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria , 2006, Microbiology and Molecular Biology Reviews.

[254]  R. Rappuoli,et al.  A pneumococcal pilus influences virulence and host inflammatory responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[255]  T. Mitchell,et al.  Innate immunity and the pneumococcus. , 2006, Microbiology.

[256]  C. Dowson,et al.  Distribution and Genetic Diversity of the ABC Transporter Lipoproteins PiuA and PiaA within Streptococcus pneumoniae and Related Streptococci , 2006, Journal of bacteriology.

[257]  S. Hammerschmidt,et al.  Versatility of pneumococcal surface proteins. , 2006, Microbiology.

[258]  S. Clarke,et al.  Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin , 2006, Journal of Clinical Microbiology.

[259]  D. Golenbock,et al.  The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease , 2005, Infection and Immunity.

[260]  K. Cartwright,et al.  Diagnosis of Invasive Pneumococcal Infection by Serotype-Specific Urinary Antigen Detection , 2005, Journal of Clinical Microbiology.

[261]  D. Isaacman,et al.  Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention , 2005, Pharmacotherapy.

[262]  D. Tamandl,et al.  Monocyte Toll-Like Receptor 4 Expression and LPS-Induced Cytokine Production Increase during Gestational Aging , 2005, Pediatric Research.

[263]  Jos Boekhorst,et al.  Genome-Wide Detection and Analysis of Cell Wall-Bound Proteins with LPxTG-Like Sorting Motifs , 2005, Journal of bacteriology.

[264]  T. Mitchell,et al.  Innate Immune Defense against Pneumococcal Pneumonia Requires Pulmonary Complement Component C3 , 2005, Infection and Immunity.

[265]  Sébastien Guiral,et al.  Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[266]  P. Godowski A smooth operator for LPS responses , 2005, Nature Immunology.

[267]  H. Leaf,et al.  Pneumococcal vaccination in adults , 2005, Current infectious disease reports.

[268]  M. Lipsitch,et al.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[269]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[270]  D. Musher,et al.  Pneumococcal virulence factors and host immune responses to them , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[271]  C. Dowson,et al.  PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia. , 2005, FEMS immunology and medical microbiology.

[272]  P. Andrew,et al.  The role of pneumolysin in pneumococcal pneumonia and meningitis , 2004, Clinical and experimental immunology.

[273]  D. Briles,et al.  Lipoprotein PsaA in Virulence of Streptococcus pneumoniae: Surface Accessibility and Role in Protection from Superoxide , 2004, Infection and Immunity.

[274]  A. Devitt,et al.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? , 2004, Immunology.

[275]  D. Briles,et al.  PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin , 2004, Infection and Immunity.

[276]  L. McDaniel,et al.  Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H1 , 2004, The Journal of Immunology.

[277]  Ulrich Dobrindt,et al.  Genomic islands in pathogenic and environmental microorganisms , 2004, Nature Reviews Microbiology.

[278]  G. Pozzi,et al.  Pneumococcal Surface Protein C Contributes to Sepsis Caused by Streptococcus pneumoniae in Mice , 2004, Infection and Immunity.

[279]  Manfred Rohde,et al.  Glyceraldehyde-3-Phosphate Dehydrogenase of Streptococcus pneumoniae Is a Surface-Displayed Plasminogen-Binding Protein , 2004, Infection and Immunity.

[280]  P. Andrew,et al.  The innate immune response to pneumococcal lung infection: the untold story. , 2004, Trends in immunology.

[281]  R. de Groot,et al.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease. , 2004, The Lancet. Infectious diseases.

[282]  David L Woodland,et al.  Jump-starting the immune system: prime-boosting comes of age. , 2004, Trends in immunology.

[283]  Herbert Schmidt,et al.  Pathogenicity Islands in Bacterial Pathogenesis , 2004, Clinical Microbiology Reviews.

[284]  J. Weiser,et al.  Factors Contributing to Hydrogen Peroxide Resistance in Streptococcus pneumoniae Include Pyruvate Oxidase (SpxB) and Avoidance of the Toxic Effects of the Fenton Reaction , 2003, Journal of bacteriology.

[285]  A. Tomasz,et al.  Inactivation of the srtA Gene Affects Localization of Surface Proteins and Decreases Adhesion of Streptococcus pneumoniae to Human Pharyngeal Cells In Vitro , 2003, Infection and Immunity.

[286]  J. Weiser,et al.  Antibody-enhanced pneumococcal adherence requires IgA1 protease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[287]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[288]  S. S. Tai,et al.  A solute binding protein of Streptococcus pneumoniae iron transport. , 2003, FEMS microbiology letters.

[289]  G. G. Hardy,et al.  Genetic Alteration of Capsule Type but Not PspA Type Affects Accessibility of Surface-Bound Complement and Surface Antigens of Streptococcus pneumoniae , 2003, Infection and Immunity.

[290]  M. Walport,et al.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[291]  R. Donlan,et al.  Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.

[292]  Jeremy S. Brown,et al.  Characterization of Pit, a Streptococcus pneumoniae Iron Uptake ABC Transporter , 2002, Infection and Immunity.

[293]  G. Pozzi,et al.  Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. , 2002, Gene.

[294]  Jeremy S. Brown,et al.  Immunization with Components of Two Iron Uptake ABC Transporters Protects Mice against Systemic Streptococcus pneumoniae Infection , 2001, Infection and Immunity.

[295]  M. J. Jedrzejas Pneumococcal Virulence Factors: Structure and Function , 2001, Microbiology and Molecular Biology Reviews.

[296]  Jeremy S. Brown,et al.  A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence , 2001, Molecular microbiology.

[297]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[298]  E. Tuomanen,et al.  Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae , 2000, Infection and Immunity.

[299]  J. Weiser,et al.  Inhibitory and Bactericidal Effects of Hydrogen Peroxide Production by Streptococcus pneumoniae on Other Inhabitants of the Upper Respiratory Tract , 2000, Infection and Immunity.

[300]  S. Hammerschmidt,et al.  Species‐specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif , 2000, Molecular microbiology.

[301]  K. Tryggvason,et al.  The macrophage receptor MARCO. , 2000, Microbes and infection.

[302]  S. Romagnani Th1/Th2 cells. , 1999, Inflammatory bowel diseases.

[303]  D. Briles,et al.  Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae , 1999, Infection and Immunity.

[304]  S. Hammerschmidt,et al.  Identification of Pneumococcal Surface Protein A as a Lactoferrin-Binding Protein of Streptococcus pneumoniae , 1999, Infection and Immunity.

[305]  M. González,et al.  LytB, a novel pneumococcal murein hydrolase essential for cell separation , 1999, Molecular microbiology.

[306]  S. Hammerschmidt,et al.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. , 1999, Infection and immunity.

[307]  J. Rubins,et al.  Pneumolysin: a multifunctional pneumococcal virulence factor. , 1998, The Journal of laboratory and clinical medicine.

[308]  C. Rosenow,et al.  Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae , 1997, Molecular microbiology.

[309]  J. Claverys,et al.  Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases , 1997, Molecular microbiology.

[310]  L. Brammer,et al.  Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[311]  J. P. Davis,et al.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[312]  A. Wanner,et al.  Mucociliary clearance in the airways. , 1996, American journal of respiratory and critical care medicine.

[313]  J. Paton,et al.  Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae , 1996, Infection and immunity.

[314]  P. Andrew,et al.  Thiol‐activated cytolysins , 1996 .

[315]  J. Paton,et al.  Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. , 1996, Microbial pathogenesis.

[316]  O. Massidda,et al.  Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis. , 1996, Microbial drug resistance.

[317]  J. Verhoef,et al.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines , 1995 .

[318]  J. Verhoef,et al.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines , 1995, Microbiological reviews.

[319]  H. Masure,et al.  Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells , 1995, Infection and immunity.

[320]  H. Masure,et al.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization , 1994, Infection and immunity.

[321]  S. S. Tai,et al.  Hemin utilization is related to virulence of Streptococcus pneumoniae , 1993, Infection and immunity.

[322]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[323]  Grossman Rf,et al.  Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. , 1993 .

[324]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[325]  P. Andrew,et al.  Molecular Analysis of The Pathogenicity of Streptococcus Pneumoniae: The Role of Pneumococcal Proteins , 1993 .

[326]  J. Granton,et al.  Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. , 1993, Clinics in chest medicine.

[327]  A. Denman Cellular and Molecular Immunology , 1992 .

[328]  J. Quinn Mechanisms of Resistance to β-Lactam Antibiotics , 1991 .

[329]  M. Proctor,et al.  Production of immunoglobulin A protease by Streptococcus pneumoniae from animals , 1990 .

[330]  R. Macgregor,et al.  Neutrophil function in healthy elderly subjects. , 1990, Journal of gerontology.

[331]  P W Andrew,et al.  Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity , 1989, Infection and immunity.

[332]  B. Gray,et al.  Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life. , 1988, The Journal of infectious diseases.

[333]  L. Grossman,et al.  Clinical, laboratory, and radiological information in the diagnosis of pneumonia in children. , 1988, Annals of emergency medicine.

[334]  J. Falloon,et al.  Neutrophil granules in health and disease. , 1986, The Journal of allergy and clinical immunology.

[335]  J. Shelhamer,et al.  Human respiratory mucous glycoproteins. , 1984, Experimental lung research.

[336]  J. Paton,et al.  Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae , 1983, Infection and immunity.

[337]  E. García,et al.  [Bacterial autolysins]. , 1983, Microbiologia espanola.

[338]  B. Gray,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.

[339]  E. Vallota,et al.  Serum Complement Levels in Infancy: Age Related Changes , 1979, Pediatric Research.

[340]  M. Hilleman,et al.  Protective efficacy of pneumococcal polysaccharide vaccines. , 1977, JAMA.

[341]  A. Tomasz THE ROLE OF AUTOLYSINS IN CELL DEATH * , 1974, Annals of the New York Academy of Sciences.

[342]  C. Forsberg,et al.  Role of Autolysins in the Killing of Bacteria by Some Bactericidal Antibiotics , 1971, Journal of bacteriology.

[343]  E. S. Robinson,et al.  The Biology of Pneumococcus; the Bacteriological, Biochemical, and Immunological Characters and Activities of Diplococcus Pneumoniae , 1938 .

[344]  T. Azarian,et al.  Pneumococcal protein antigen serology varies with age and may predict antigenic 1 profile of colonizing isolates 2 3 , 2022 .

[345]  Innate Immunity : The First Lines of Defense 2 , 2022 .